Human Leukocyte Antigen Typing and Tumor Antigen Expression Profiling
Recruiting in Palo Alto (17 mi)
+4 other locations
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: Immatics US, Inc.
No Placebo Group
Trial Summary
What is the purpose of this trial?
This screening study will identify HLA molecular subtype positive and tumor antigen target(s) positive patients who may be eligible for enrollment into Immatics clinical studies. This screening study is intended for patients with advanced and/or metastatic solid cancers. No treatment intervention will occur as part of this screening study.
Eligibility Criteria
Inclusion Criteria
Patients ≥ 18 years of age
Signed an Informed Consent Form (ICF)
Patients with confirmed advanced and/or metastatic solid tumors.
See 7 more
Treatment Details
Interventions
- Human Leukocyte Antigen Typing and Tumor Antigen Expression Profiling (Other)
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Immatics USHouston, TX
Oncology ConsultantsHouston, TX
Columbia University Medical CenterNew York, NY
University of Pittsburgh Medical CenterPittsburgh, PA
More Trial Locations
Loading ...
Who Is Running the Clinical Trial?
Immatics US, Inc.Lead Sponsor